|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:VAPA-GDAP2 (FusionGDB2 ID:97210) |
Fusion Gene Summary for VAPA-GDAP2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: VAPA-GDAP2 | Fusion gene ID: 97210 | Hgene | Tgene | Gene symbol | VAPA | GDAP2 | Gene ID | 9218 | 54834 |
Gene name | VAMP associated protein A | ganglioside induced differentiation associated protein 2 | |
Synonyms | VAP-33|VAP-A|VAP33|hVAP-33 | MACROD3|SCAR27 | |
Cytomap | 18p11.22 | 1p12 | |
Type of gene | protein-coding | protein-coding | |
Description | vesicle-associated membrane protein-associated protein A33 kDa VAMP-associated proteinVAMP (vesicle-associated membrane protein)-associated protein A, 33kDaVAMP-Aepididymis secretory sperm binding protein | ganglioside-induced differentiation-associated protein 2 | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | . | Q9NXN4 | |
Ensembl transtripts involved in fusion gene | ENST00000400000, ENST00000340541, ENST00000584796, | ENST00000369443, ENST00000369442, ENST00000464026, | |
Fusion gene scores | * DoF score | 9 X 4 X 7=252 | 4 X 3 X 2=24 |
# samples | 10 | 4 | |
** MAII score | log2(10/252*10)=-1.33342373372519 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/24*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: VAPA [Title/Abstract] AND GDAP2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | VAPA(9914332)-GDAP2(118413238), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | VAPA | GO:0044791 | positive regulation by host of viral release from host cell | 19515777 |
Hgene | VAPA | GO:0044828 | negative regulation by host of viral genome replication | 19515777 |
Hgene | VAPA | GO:0044829 | positive regulation by host of viral genome replication | 19515777 |
Fusion gene breakpoints across VAPA (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across GDAP2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-CD-8525-01A | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - |
Top |
Fusion Gene ORF analysis for VAPA-GDAP2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000400000 | ENST00000369443 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - |
5CDS-intron | ENST00000400000 | ENST00000369442 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - |
5CDS-intron | ENST00000400000 | ENST00000464026 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - |
In-frame | ENST00000340541 | ENST00000369443 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - |
5CDS-intron | ENST00000340541 | ENST00000369442 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - |
5CDS-intron | ENST00000340541 | ENST00000464026 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - |
intron-3CDS | ENST00000584796 | ENST00000369443 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - |
intron-intron | ENST00000584796 | ENST00000369442 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - |
intron-intron | ENST00000584796 | ENST00000464026 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000400000 | VAPA | chr18 | 9914332 | + | ENST00000369443 | GDAP2 | chr1 | 118413238 | - | 7466 | 334 | 55 | 381 | 108 |
ENST00000340541 | VAPA | chr18 | 9914332 | + | ENST00000369443 | GDAP2 | chr1 | 118413238 | - | 7406 | 274 | 4 | 321 | 105 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000400000 | ENST00000369443 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - | 0.8568934 | 0.14310655 |
ENST00000340541 | ENST00000369443 | VAPA | chr18 | 9914332 | + | GDAP2 | chr1 | 118413238 | - | 0.85328704 | 0.14671294 |
Top |
Fusion Genomic Features for VAPA-GDAP2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for VAPA-GDAP2 |
Go to FGviewer for the breakpoints of chr18:9914332-chr1:118413238 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | GDAP2 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | GDAP2 | chr18:9914332 | chr1:118413238 | ENST00000369442 | 0 | 13 | 333_481 | 0 | 497.0 | Domain | Note=CRAL-TRIO | |
Tgene | GDAP2 | chr18:9914332 | chr1:118413238 | ENST00000369442 | 0 | 13 | 43_223 | 0 | 497.0 | Domain | Macro |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | VAPA | chr18:9914332 | chr1:118413238 | ENST00000340541 | + | 1 | 7 | 169_205 | 26.333333333333332 | 295.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | VAPA | chr18:9914332 | chr1:118413238 | ENST00000400000 | + | 1 | 6 | 169_205 | 26.333333333333332 | 250.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | VAPA | chr18:9914332 | chr1:118413238 | ENST00000340541 | + | 1 | 7 | 14_131 | 26.333333333333332 | 295.0 | Domain | MSP |
Hgene | VAPA | chr18:9914332 | chr1:118413238 | ENST00000400000 | + | 1 | 6 | 14_131 | 26.333333333333332 | 250.0 | Domain | MSP |
Hgene | VAPA | chr18:9914332 | chr1:118413238 | ENST00000340541 | + | 1 | 7 | 2_227 | 26.333333333333332 | 295.0 | Topological domain | Cytoplasmic |
Hgene | VAPA | chr18:9914332 | chr1:118413238 | ENST00000400000 | + | 1 | 6 | 2_227 | 26.333333333333332 | 250.0 | Topological domain | Cytoplasmic |
Hgene | VAPA | chr18:9914332 | chr1:118413238 | ENST00000340541 | + | 1 | 7 | 228_248 | 26.333333333333332 | 295.0 | Transmembrane | Helical%3B Anchor for type IV membrane protein |
Hgene | VAPA | chr18:9914332 | chr1:118413238 | ENST00000400000 | + | 1 | 6 | 228_248 | 26.333333333333332 | 250.0 | Transmembrane | Helical%3B Anchor for type IV membrane protein |
Tgene | GDAP2 | chr18:9914332 | chr1:118413238 | ENST00000369443 | 12 | 14 | 333_481 | 482.0 | 498.0 | Domain | Note=CRAL-TRIO | |
Tgene | GDAP2 | chr18:9914332 | chr1:118413238 | ENST00000369443 | 12 | 14 | 43_223 | 482.0 | 498.0 | Domain | Macro |
Top |
Fusion Gene Sequence for VAPA-GDAP2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000400000_ENST00000369443_TCGA-CD-8525-01A_VAPA_chr18_9914332_+_GDAP2_chr1_118413238_length(transcript)=7466nt_BP=334nt TCACGTGGGTCGCCGAGGCTCGCAAGTGCGCGTGGCCGTGGCGGCTGGTGTGGGGTTGAGTCAGTTGTGGGACCCGGAGCTGCTGACCCA GCGGGTGGCCCACCGAACCGGTGACACAGCGGCAGGCGTTAGGGCTCGGGAGCCGCGAGCCTGGCCTCGTCCTAGAGCTCGGCCGAGCCG TCGCCGCCGTCGTCCCCCGCCCCCAGTCAGCAAACCGCCGCCGCGGGCGCGCCCCCGCTCTGCGCTGTCTCTCCGATGGCGTCCGCCTCA GGGGCCATGGCGAAGCACGAGCAGATCCTGGTCCTCGATCCGCCCACAGACCTCAAATTCAAAGGAAAACGGGCCTTACTATACATCATA TCCCCCATCACCAGATTTGTGACCTGCCATCTTTCAGTGCTTCTTGGTTCCCAGGATGCCACTTCCTCCACGAATAGCTACCTGTTGAAG TGATATTCATTGTTGCTGTACAGATCCAGAGAGCCTTTTGTCCCCACCTCTCTGGTATTTTTTTATTGACTGTATATTTTCTGGCACATA AGCAATCTAAAAATGGTAGGCCATTCTGAACTGCACACATTTTAAATTTGTATATTTATATGAAATGGAAATGTTCATTTTTAGATTGTT AATAGAAATTGGGGAGCAACTTTTGAGTATCTTTAGTTTCCTGAAGGACACCGAATTCTCCATTAGATAAACCACCAAGACTGTTCACAT CATCTCTCTAACATTGCACGCTTCCTTTGTGTACTTAAGTGATTCTCGAAATATACAGAACCAATGTATGCTAACCAGATGCATTGTTTG CTTCAGATCCATGGTGTTAATACCATGTATATTTTATAAAGATAATTTGGCTGTGTTAAAAGAGAATTACCTGAGTCCAAGAATGTGGAA ATGTATCTGACAAAAAACATCAAAATCATTAGCAAAACATAGGACTTAGAATGTTAATGTACAAGTTAAGACTAAAGTTTAAGGACTAAG GTTCCTTGGATTATATGACTTGTTAAGATTGCCACAGTTCCGATCTCAACAGTGTGGGGTGAAACAAGAAGACTGTATCTTCAGCCTTTT TCCTATAATCATGGATGATTTGGTCTTATTCAAAAGGACCGCACATATTAGTACTCTTAAGAGCATCTTCCAAGACTCCAGCAGTGAGCA TTTAGAGAGTGTGTTGTCTTCCAGAGTCATGAATGATTTTGTTTAGCTATCAGGTCTACTACCTCTAAGGACATTTCATAGCAGCATCTC TTGAGTTGCCTGCATCAGTGTGGAGGAAGTGTGTCACAGTGAACAAATCCAGGGAGCTGATAATTGGCAAAAGACCACTTTTACCACTCA GGCTCTATTTGTGCCTTAGCTTGGTTATGAGTAAAAATTAGAATTATGCTGCCTACCTCACAGAGGTATCATGAAGATAGCATTTAGAAA GGGCTTTGTTGTGGTGGGGTATCTTCAGTTAGTTTTTAAATGGGAATAAATATATATGAGGGAATGCTACACAGCACTCCTCTTGTCCTT GATACCATTTGAGTGATTTTTCTTTTTGTGTGGCAATACCTGTTAGTGTAAAATTCCAACCCTGATGACCTCCTTCCTCTTTTGTCCAGA ATCTCTTCTGGCCTGCTCATCCCCTGATGCTATACTTCAATAAGAGGCATCTGTTGGCCATTTTAAACATTTCTTCTTGAATTAAGGTCA AACCATTATTATTCCCATCTGGGTAGCTTTGTACTTTTTTTGATTCCTACAGCCACCTCCCCACAGCCCCATCTTCCTCACCCCATCACG TACATTGGCAGTTCAGAGAAAAAAAAAAGCAGAACCTTTCTGTTCTATCATGTGCTCCAGATCAGTGCTTCCAAGGGTCCCATTCTTTTC TGCCCAAACTAATTCTTCATTGGAGATCAAAGAAACATATTCTCTTCATTTATGATAGGGAAATGCCCCTATAGTGCATTAAATTCATCC TGTATTTTCCCATATAAACAAGAAGAGACTTTACATTTTTTAGATAAAGGTTCTTATCTTTTGCATGTATTGAACACATTTTCTTTGTGT CAGACCTCAAAATTACTTGATCCTTATATATACATCTATGTTAAGATTTTCTCTTATGTCCCCTAGGTCATCACATCCAGGCAGCCAGTC AGATGTCGGATGTTAAGCTTTCTCTCAAACAGTACTTTTTTTTTAACCCCTTGGGCACTGTACCTTAAAAGTCTGCAACTTTAACTTCAT CTTCTACAGTCAATCGTGAGATCATATTTGAGGTATCTTCTTCACAAGGAGCAGCTATGAAAGTCTGCCAACTTTTCTTTGTTAAAGGGG AACTTGGCTACCTCAAGAACCTGGCCCAAACCATTTTCTGTAGAGATAATAGAGGCCGTAAGCTACTTTGCCAATTTGAAAGGAAGCAAA TTTATATATACAATTTCTTACAGGCAATGATTTTGAAAGGATGTTCCTTTGCTATATTCATACCAGTATATTAATGTTTAGTAACACAAG CAGGATTCTACATATGCTGAGATTTTAGTACAATTGATGTCCTAGGGTATAAAGGTGATACAGAACTATATACATATCAACTGTGTTTTA TAATTCAATGATGACTAAAGAAAGATAAGGACCACTCTTCTCACTGAAACTAAATTTGATGTGGGACCAAGTTCATGCTTTTATAGATGT CTAAAGTGTTATAGAATGAAGTTGCTTCAAAGTACCAAATCCTAGAGGAGAAATATAATGACCTTGATATTGAAATGATTAAGCAACATT TGGTATACCAATCTGCCTTTGTGAAAAGGTTTAGCCTGAATAATACATGCCATTTTCAAGGACATATTAGAGGATAAAGGGGATACTGGA TGGAGATGACCACCAGCATCTGATGTTAATTCAAAGCACCACCAAGTCTTTAATTTAATTAAACTTTGGTCATGCCAAATGCTAATTGAA TTGTTGAAGACACAAGTTATAAAATATTAATTTATTAATCATGCAAGGCATAATATGATTTTTAAAACAAGTACACTTCTTGCTTCCACG TGTATTTGGGTTCTTAATTCATCTATATCCAAGTTTCTTGATAGTGAAAATTACCTCTTAAAAAAGGTTCAGCCTTTATTAGACTCGTGA GGGCAAATGGTACATATTTTAAAGACGTTTTCTCCTTTAATGTATATTATGTTTCATTGGCGGATGCTTTATATTTCCTTTTTCTTTTTC TTTTTTTTTTGGAGACAGTCTTACTCTGTCACCCAAGCTGGAGTGCAATGGTGTGATCTCGGCTCACTGCAGCCTCGGCCTCCCAGGTTT AAGTGGTTCTCCTGCCTCAGCCTCCCTAGTAGCTGGGACTACAGGTGCCTGCCACCATGCCTGGCTAATTTTTTTTTTTTTTTTTTTTTT TTTCAGTAGAGACAGGGTTTCACCATGTTGGCCAGACTGGTCTCAAACTCCTGACCTCAAGTGATCTTCCTGCCTCGGCCTCCCAAAGTG TTGGGCTTACCAGTATGAGCCACCGTGCCCATCCTGTATTTCCTTTTTCAAAGGAATACATCTGCAGTATTTTGAGAGTAATTAGCAGAG GGTTTTTTGAGTATTTTTGGTAGGAAAAATAGATGTAGTTTTTTAATCAAATTTCTGAAATTGAAAATATCACTTCTTTTTAAAGAGGGA TAAGTATAGTCACTCTAGTAGAAAAACATGGCTTGCCTATTTCCTCTTCTTTTCTGTTTGCTTGGATATTGTTTAATGAATTCAAACTGT AGGTTTAGTCTTGTCTTTATAACAGTTAATGGAGAAGTGATAAAATTAAGTATTCAGCATAAACTAAAGATCACTCTTTGTATTTCCCCG ATACATTGACAGTATGTATGTATATAGAGTTTAAATTGCTTAATATATGCACAGAAATGATTAGAATTTGAAGTACTATATAGAGGAGAG TTACATGGTTCTAGTGGCAGTGGATTGATTGTATTAAGGACCAAAAGAACTGCAGGATAATATAAAAACACCTTGAAAACTGGAGTTAGT TAGGTTTCTTTTTCTTTTTCTTTTTTTTTTTTAAAGGGCCTTACTGTACTTTTTTTTTTTTTTTGGTCACCCAGGCTGGAGTGCAATGGC ACGATCTCGGCTCACTGTAATCTCTGTCTCCTGGGTTCAAGAGATTCTCCTGTCTCAGCCTCCCCAGTAAGTGAGATTATAGACATGCAC CACCATGCCCGGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAGGCTGCTCTCGAATTCCTGACCTCAGGTGAT CTGCCCACCTTGGCTTCTCAAAGTGCCAGATTACAGGCATAAGCCACTGTGCCTGGCCAGGTTTCTGATTATAGTTTTCTTAAGTTGTAA TCATCATAATTAACGTGCGCTAGAGTGTTTTAACTGTGCTGGCACTAATGCTTCTTGGCATATAATTAACTCTTGTTTTGCAAAAAGACC ATGAAGAATGAAAGGAGGGCTTTACCTTACCTTAGTCATTTTGGGTGAATACCGTAAACTGGGTGGCGTAACAAAACACATTTATTTCTC ACAGTTGGAGGCTGAGAAACCCCAAGATCAAAGTGCCATCCAGCGCAATTCCTGATGAGGGCCCTCTTCTGGCTTCTTGCTGTATTCTCA CTTGGCAGAGAGAGAGAGACATCGTTACTTTCCTGTCTCTTCTTATAAGGGCACTAATCTCATTCATGAGGGCTCCACCCTCATGACATG ATTACCACCCAGAGGCCCCACCTCCAAATGCCATCACTTTGTATGTTAGGGCTTCAACATATGAATTTGCAGACGAGGAGGAGAACATAA GCATTCAGTTCATAACATACCTATAATCTAGGTCATATCATAAACCCAGAGATGATAAGGATTGCCTGGTAGGCCTAACCATATATACAT ATACATGCATGCACACACACATATATGCATAATCTGCCTTGTTTTACATTCTTTGAGTCGGACTTCTGTGGTCCATATGTAGAGAACATA GAGCAATAAATAACCTAGTTCAATCTTTGAGTCTTACTGAACTAGTCCTTAAACAGATGGTATCAAGATCATTTTAGATATTAGTGACTC TCTTGTATATTAGTTATTTTTTACACTTTTAAGAACAGCATCTTTGAATCTTTTCAAGTACAGTATGCCTTAAATGTATAGGACCACTGA GTTCAGGAAGAAAAGCATAGGTATTCTGTAGGTGAATTACACTAACAAAATCACAACTGCAGAATGTGATCTGATACTTTTGTTGGACAG TAAAGCTAATACATTTTATATACACAGTCATACCTTTTTTTTTTGTAATGTGTTTCGTTAACGTAAGCACACAGTCATCACAGACTGAGA CAGGACTTTGTTAGACCAGATCTTGTGAGCTAAATATTTAAGAGCTTAACATATATAAATGATTTTAATTGGTATTGGGCGAAGGAAACC TAAAAATGCTTAAATTGACAGATCTTACAATTTGCTTACTGAAAATTCAGAAAGCTTTTATGAAAACTTTGTATTTTAAAATATTTTTTG CTCATTCTGAATTAGAAGTTAGATCCCTTTTAAAGAGGGTCTCACTCTATACAAATATAGCCTATGAAGAATCAATAGTGAAATAATAGT GTTTATATTGAACCCCAGGATGGGACATTATTTTTTGACCATTTACATGAGGTCTTTCTCTAATTACCAAAGTTAACCTTAAGAGTAGTT AAAAACTCAGTGAATTTTAGTCAACATTCTCTGTGGAGACCTGGACTAGTGTTTCCCAAACTTTCATGTGCATGTATCAAATCAGCTGAG GATATTATTAAATGGAGATTCAGATTCAATAGTTCTGGGGTGGCCTCTGGGATTATCAGTTTCTAACAAGCTCTTAGGTGTTATCAATTC TCCTGGTCCCCAGACCATAGTTAGAGTAAAAGAGTATAGACTGCATTTAGCTTCCAGATTTTCTCTTTCAAGGAAAGGAGACAGAACTGT CATTGTAATTCTTCCTGTGGTCCAGGCACTCTAACGTTCATCGTCTCTTCTAATGCTCTTACAAATCCTGTGAGGTTGGTGATAATAGAA GTTACCTCCTGAAGACGACATTCACAAGCAGGACCGACCGTGTAGACCAGTTTTCTCAAACTGAATAATGTACTTCACTTTTTAATAAGG AAAAAAATCTCTTAGCTCCTCAGTTTTTGCTTAATTTATATTTATTATAATGTTATCTAAATATATATAAACATAAAACTAGGTATAAAT GCTTTATGTTTATATGTCTTGCACAAGTATAAAACCAAAACAAGTTTATGGGTTAACACAAGCAAAACTATAAAACTAATAAAATTTAAA ATAGTATTAAATAGTGATGTTTTGACAAAATGAAATTGTCACTTGTAATGTGATTATGGTACTGAGTGCTACAGTACAGGCTCTTTTCAG TTCAACAGGCATGTACTGCCATGTACTATGTGATGACCCAATTCACCCTGTTTTCTCCTATTCAGACTATTACTTTAATTTGTTCAGCAC ATAGTGATGTTATTTGGTCCTCATCTAGCCTGAATCCATCATTCCCCTATTAAAACAGCCTCTGTTCTCCATAAGCCTTCCACCACTAAT GTAGAACTGGGCCTTAACAGGGAAGTCAATACAAATACAAACCTAAGCACTGAGATGGTTCTGCCAATATTTGGTTTTAATACAATTATC CAAATAATTCAGAGCATGAATATTATTTTAAAATGTTTCATCAACATGAATAATGCATAATTCTCATAGTAAGTTCATGGGCACTTTCCT ACACCCAACACATATATACTCCACAAGGATTTTGCATGGACCCCAGTTTAAGAAGCAACAATTTAGTGGTCAGTAGCATTGGCGCTTTGG CTTCTGACACACTCAGACCTTGGGCCTGTTTCTCAACTTTTTCTGAACCTCAGTGTTTTTGTGTATTCAACAGGGATAATATTAATTGAA TAATTAGGAGGAACAAATGCAATAATGTACATAAAGCATGCATAGTAGTGTTTATAAATAGCAGCCACCACTGCTTTGATTAGAAATAAT AACAGCTAACATTTGAGGATTTACTGTGTGCCTTGAACGCTGCTAAGCTCTTTATATATATTACATATTGAGTGGTAGAATCAGGATTCA AATCCAGATCTGACTCCAAAGCGCATGCTTTTATAAAACATAATTTAAATATAGAATATCAATGTAAATTGCTTATTTAGAAAGTTTATT TTCTTATATTTTCTCAAAAATATTTATTGTCAAATCAGTGATTCTGTAGAGGGGTAAATAGCTAAATTTCCTTTTAAAAATTGTATGATG >In-frame_ENST00000400000_ENST00000369443_TCGA-CD-8525-01A_VAPA_chr18_9914332_+_GDAP2_chr1_118413238_length(amino acids)=108AA_start in transcript=55_stop in transcript=381 MSQLWDPELLTQRVAHRTGDTAAGVRAREPRAWPRPRARPSRRRRRPPPPVSKPPPRARPRSALSLRWRPPQGPWRSTSRSWSSIRPQTS -------------------------------------------------------------- >In-frame_ENST00000340541_ENST00000369443_TCGA-CD-8525-01A_VAPA_chr18_9914332_+_GDAP2_chr1_118413238_length(transcript)=7406nt_BP=274nt TCAGTTGTGGGACCCGGAGCTGCTGACCCAGCGGGTGGCCCACCGAACCGGTGACACAGCGGCAGGCGTTAGGGCTCGGGAGCCGCGAGC CTGGCCTCGTCCTAGAGCTCGGCCGAGCCGTCGCCGCCGTCGTCCCCCGCCCCCAGTCAGCAAACCGCCGCCGCGGGCGCGCCCCCGCTC TGCGCTGTCTCTCCGATGGCGTCCGCCTCAGGGGCCATGGCGAAGCACGAGCAGATCCTGGTCCTCGATCCGCCCACAGACCTCAAATTC AAAGGAAAACGGGCCTTACTATACATCATATCCCCCATCACCAGATTTGTGACCTGCCATCTTTCAGTGCTTCTTGGTTCCCAGGATGCC ACTTCCTCCACGAATAGCTACCTGTTGAAGTGATATTCATTGTTGCTGTACAGATCCAGAGAGCCTTTTGTCCCCACCTCTCTGGTATTT TTTTATTGACTGTATATTTTCTGGCACATAAGCAATCTAAAAATGGTAGGCCATTCTGAACTGCACACATTTTAAATTTGTATATTTATA TGAAATGGAAATGTTCATTTTTAGATTGTTAATAGAAATTGGGGAGCAACTTTTGAGTATCTTTAGTTTCCTGAAGGACACCGAATTCTC CATTAGATAAACCACCAAGACTGTTCACATCATCTCTCTAACATTGCACGCTTCCTTTGTGTACTTAAGTGATTCTCGAAATATACAGAA CCAATGTATGCTAACCAGATGCATTGTTTGCTTCAGATCCATGGTGTTAATACCATGTATATTTTATAAAGATAATTTGGCTGTGTTAAA AGAGAATTACCTGAGTCCAAGAATGTGGAAATGTATCTGACAAAAAACATCAAAATCATTAGCAAAACATAGGACTTAGAATGTTAATGT ACAAGTTAAGACTAAAGTTTAAGGACTAAGGTTCCTTGGATTATATGACTTGTTAAGATTGCCACAGTTCCGATCTCAACAGTGTGGGGT GAAACAAGAAGACTGTATCTTCAGCCTTTTTCCTATAATCATGGATGATTTGGTCTTATTCAAAAGGACCGCACATATTAGTACTCTTAA GAGCATCTTCCAAGACTCCAGCAGTGAGCATTTAGAGAGTGTGTTGTCTTCCAGAGTCATGAATGATTTTGTTTAGCTATCAGGTCTACT ACCTCTAAGGACATTTCATAGCAGCATCTCTTGAGTTGCCTGCATCAGTGTGGAGGAAGTGTGTCACAGTGAACAAATCCAGGGAGCTGA TAATTGGCAAAAGACCACTTTTACCACTCAGGCTCTATTTGTGCCTTAGCTTGGTTATGAGTAAAAATTAGAATTATGCTGCCTACCTCA CAGAGGTATCATGAAGATAGCATTTAGAAAGGGCTTTGTTGTGGTGGGGTATCTTCAGTTAGTTTTTAAATGGGAATAAATATATATGAG GGAATGCTACACAGCACTCCTCTTGTCCTTGATACCATTTGAGTGATTTTTCTTTTTGTGTGGCAATACCTGTTAGTGTAAAATTCCAAC CCTGATGACCTCCTTCCTCTTTTGTCCAGAATCTCTTCTGGCCTGCTCATCCCCTGATGCTATACTTCAATAAGAGGCATCTGTTGGCCA TTTTAAACATTTCTTCTTGAATTAAGGTCAAACCATTATTATTCCCATCTGGGTAGCTTTGTACTTTTTTTGATTCCTACAGCCACCTCC CCACAGCCCCATCTTCCTCACCCCATCACGTACATTGGCAGTTCAGAGAAAAAAAAAAGCAGAACCTTTCTGTTCTATCATGTGCTCCAG ATCAGTGCTTCCAAGGGTCCCATTCTTTTCTGCCCAAACTAATTCTTCATTGGAGATCAAAGAAACATATTCTCTTCATTTATGATAGGG AAATGCCCCTATAGTGCATTAAATTCATCCTGTATTTTCCCATATAAACAAGAAGAGACTTTACATTTTTTAGATAAAGGTTCTTATCTT TTGCATGTATTGAACACATTTTCTTTGTGTCAGACCTCAAAATTACTTGATCCTTATATATACATCTATGTTAAGATTTTCTCTTATGTC CCCTAGGTCATCACATCCAGGCAGCCAGTCAGATGTCGGATGTTAAGCTTTCTCTCAAACAGTACTTTTTTTTTAACCCCTTGGGCACTG TACCTTAAAAGTCTGCAACTTTAACTTCATCTTCTACAGTCAATCGTGAGATCATATTTGAGGTATCTTCTTCACAAGGAGCAGCTATGA AAGTCTGCCAACTTTTCTTTGTTAAAGGGGAACTTGGCTACCTCAAGAACCTGGCCCAAACCATTTTCTGTAGAGATAATAGAGGCCGTA AGCTACTTTGCCAATTTGAAAGGAAGCAAATTTATATATACAATTTCTTACAGGCAATGATTTTGAAAGGATGTTCCTTTGCTATATTCA TACCAGTATATTAATGTTTAGTAACACAAGCAGGATTCTACATATGCTGAGATTTTAGTACAATTGATGTCCTAGGGTATAAAGGTGATA CAGAACTATATACATATCAACTGTGTTTTATAATTCAATGATGACTAAAGAAAGATAAGGACCACTCTTCTCACTGAAACTAAATTTGAT GTGGGACCAAGTTCATGCTTTTATAGATGTCTAAAGTGTTATAGAATGAAGTTGCTTCAAAGTACCAAATCCTAGAGGAGAAATATAATG ACCTTGATATTGAAATGATTAAGCAACATTTGGTATACCAATCTGCCTTTGTGAAAAGGTTTAGCCTGAATAATACATGCCATTTTCAAG GACATATTAGAGGATAAAGGGGATACTGGATGGAGATGACCACCAGCATCTGATGTTAATTCAAAGCACCACCAAGTCTTTAATTTAATT AAACTTTGGTCATGCCAAATGCTAATTGAATTGTTGAAGACACAAGTTATAAAATATTAATTTATTAATCATGCAAGGCATAATATGATT TTTAAAACAAGTACACTTCTTGCTTCCACGTGTATTTGGGTTCTTAATTCATCTATATCCAAGTTTCTTGATAGTGAAAATTACCTCTTA AAAAAGGTTCAGCCTTTATTAGACTCGTGAGGGCAAATGGTACATATTTTAAAGACGTTTTCTCCTTTAATGTATATTATGTTTCATTGG CGGATGCTTTATATTTCCTTTTTCTTTTTCTTTTTTTTTTGGAGACAGTCTTACTCTGTCACCCAAGCTGGAGTGCAATGGTGTGATCTC GGCTCACTGCAGCCTCGGCCTCCCAGGTTTAAGTGGTTCTCCTGCCTCAGCCTCCCTAGTAGCTGGGACTACAGGTGCCTGCCACCATGC CTGGCTAATTTTTTTTTTTTTTTTTTTTTTTTTCAGTAGAGACAGGGTTTCACCATGTTGGCCAGACTGGTCTCAAACTCCTGACCTCAA GTGATCTTCCTGCCTCGGCCTCCCAAAGTGTTGGGCTTACCAGTATGAGCCACCGTGCCCATCCTGTATTTCCTTTTTCAAAGGAATACA TCTGCAGTATTTTGAGAGTAATTAGCAGAGGGTTTTTTGAGTATTTTTGGTAGGAAAAATAGATGTAGTTTTTTAATCAAATTTCTGAAA TTGAAAATATCACTTCTTTTTAAAGAGGGATAAGTATAGTCACTCTAGTAGAAAAACATGGCTTGCCTATTTCCTCTTCTTTTCTGTTTG CTTGGATATTGTTTAATGAATTCAAACTGTAGGTTTAGTCTTGTCTTTATAACAGTTAATGGAGAAGTGATAAAATTAAGTATTCAGCAT AAACTAAAGATCACTCTTTGTATTTCCCCGATACATTGACAGTATGTATGTATATAGAGTTTAAATTGCTTAATATATGCACAGAAATGA TTAGAATTTGAAGTACTATATAGAGGAGAGTTACATGGTTCTAGTGGCAGTGGATTGATTGTATTAAGGACCAAAAGAACTGCAGGATAA TATAAAAACACCTTGAAAACTGGAGTTAGTTAGGTTTCTTTTTCTTTTTCTTTTTTTTTTTTAAAGGGCCTTACTGTACTTTTTTTTTTT TTTTGGTCACCCAGGCTGGAGTGCAATGGCACGATCTCGGCTCACTGTAATCTCTGTCTCCTGGGTTCAAGAGATTCTCCTGTCTCAGCC TCCCCAGTAAGTGAGATTATAGACATGCACCACCATGCCCGGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAG GCTGCTCTCGAATTCCTGACCTCAGGTGATCTGCCCACCTTGGCTTCTCAAAGTGCCAGATTACAGGCATAAGCCACTGTGCCTGGCCAG GTTTCTGATTATAGTTTTCTTAAGTTGTAATCATCATAATTAACGTGCGCTAGAGTGTTTTAACTGTGCTGGCACTAATGCTTCTTGGCA TATAATTAACTCTTGTTTTGCAAAAAGACCATGAAGAATGAAAGGAGGGCTTTACCTTACCTTAGTCATTTTGGGTGAATACCGTAAACT GGGTGGCGTAACAAAACACATTTATTTCTCACAGTTGGAGGCTGAGAAACCCCAAGATCAAAGTGCCATCCAGCGCAATTCCTGATGAGG GCCCTCTTCTGGCTTCTTGCTGTATTCTCACTTGGCAGAGAGAGAGAGACATCGTTACTTTCCTGTCTCTTCTTATAAGGGCACTAATCT CATTCATGAGGGCTCCACCCTCATGACATGATTACCACCCAGAGGCCCCACCTCCAAATGCCATCACTTTGTATGTTAGGGCTTCAACAT ATGAATTTGCAGACGAGGAGGAGAACATAAGCATTCAGTTCATAACATACCTATAATCTAGGTCATATCATAAACCCAGAGATGATAAGG ATTGCCTGGTAGGCCTAACCATATATACATATACATGCATGCACACACACATATATGCATAATCTGCCTTGTTTTACATTCTTTGAGTCG GACTTCTGTGGTCCATATGTAGAGAACATAGAGCAATAAATAACCTAGTTCAATCTTTGAGTCTTACTGAACTAGTCCTTAAACAGATGG TATCAAGATCATTTTAGATATTAGTGACTCTCTTGTATATTAGTTATTTTTTACACTTTTAAGAACAGCATCTTTGAATCTTTTCAAGTA CAGTATGCCTTAAATGTATAGGACCACTGAGTTCAGGAAGAAAAGCATAGGTATTCTGTAGGTGAATTACACTAACAAAATCACAACTGC AGAATGTGATCTGATACTTTTGTTGGACAGTAAAGCTAATACATTTTATATACACAGTCATACCTTTTTTTTTTGTAATGTGTTTCGTTA ACGTAAGCACACAGTCATCACAGACTGAGACAGGACTTTGTTAGACCAGATCTTGTGAGCTAAATATTTAAGAGCTTAACATATATAAAT GATTTTAATTGGTATTGGGCGAAGGAAACCTAAAAATGCTTAAATTGACAGATCTTACAATTTGCTTACTGAAAATTCAGAAAGCTTTTA TGAAAACTTTGTATTTTAAAATATTTTTTGCTCATTCTGAATTAGAAGTTAGATCCCTTTTAAAGAGGGTCTCACTCTATACAAATATAG CCTATGAAGAATCAATAGTGAAATAATAGTGTTTATATTGAACCCCAGGATGGGACATTATTTTTTGACCATTTACATGAGGTCTTTCTC TAATTACCAAAGTTAACCTTAAGAGTAGTTAAAAACTCAGTGAATTTTAGTCAACATTCTCTGTGGAGACCTGGACTAGTGTTTCCCAAA CTTTCATGTGCATGTATCAAATCAGCTGAGGATATTATTAAATGGAGATTCAGATTCAATAGTTCTGGGGTGGCCTCTGGGATTATCAGT TTCTAACAAGCTCTTAGGTGTTATCAATTCTCCTGGTCCCCAGACCATAGTTAGAGTAAAAGAGTATAGACTGCATTTAGCTTCCAGATT TTCTCTTTCAAGGAAAGGAGACAGAACTGTCATTGTAATTCTTCCTGTGGTCCAGGCACTCTAACGTTCATCGTCTCTTCTAATGCTCTT ACAAATCCTGTGAGGTTGGTGATAATAGAAGTTACCTCCTGAAGACGACATTCACAAGCAGGACCGACCGTGTAGACCAGTTTTCTCAAA CTGAATAATGTACTTCACTTTTTAATAAGGAAAAAAATCTCTTAGCTCCTCAGTTTTTGCTTAATTTATATTTATTATAATGTTATCTAA ATATATATAAACATAAAACTAGGTATAAATGCTTTATGTTTATATGTCTTGCACAAGTATAAAACCAAAACAAGTTTATGGGTTAACACA AGCAAAACTATAAAACTAATAAAATTTAAAATAGTATTAAATAGTGATGTTTTGACAAAATGAAATTGTCACTTGTAATGTGATTATGGT ACTGAGTGCTACAGTACAGGCTCTTTTCAGTTCAACAGGCATGTACTGCCATGTACTATGTGATGACCCAATTCACCCTGTTTTCTCCTA TTCAGACTATTACTTTAATTTGTTCAGCACATAGTGATGTTATTTGGTCCTCATCTAGCCTGAATCCATCATTCCCCTATTAAAACAGCC TCTGTTCTCCATAAGCCTTCCACCACTAATGTAGAACTGGGCCTTAACAGGGAAGTCAATACAAATACAAACCTAAGCACTGAGATGGTT CTGCCAATATTTGGTTTTAATACAATTATCCAAATAATTCAGAGCATGAATATTATTTTAAAATGTTTCATCAACATGAATAATGCATAA TTCTCATAGTAAGTTCATGGGCACTTTCCTACACCCAACACATATATACTCCACAAGGATTTTGCATGGACCCCAGTTTAAGAAGCAACA ATTTAGTGGTCAGTAGCATTGGCGCTTTGGCTTCTGACACACTCAGACCTTGGGCCTGTTTCTCAACTTTTTCTGAACCTCAGTGTTTTT GTGTATTCAACAGGGATAATATTAATTGAATAATTAGGAGGAACAAATGCAATAATGTACATAAAGCATGCATAGTAGTGTTTATAAATA GCAGCCACCACTGCTTTGATTAGAAATAATAACAGCTAACATTTGAGGATTTACTGTGTGCCTTGAACGCTGCTAAGCTCTTTATATATA TTACATATTGAGTGGTAGAATCAGGATTCAAATCCAGATCTGACTCCAAAGCGCATGCTTTTATAAAACATAATTTAAATATAGAATATC AATGTAAATTGCTTATTTAGAAAGTTTATTTTCTTATATTTTCTCAAAAATATTTATTGTCAAATCAGTGATTCTGTAGAGGGGTAAATA GCTAAATTTCCTTTTAAAAATTGTATGATGTGCTGATTTCAAATTGATGTGAAATACAGATTTCATTTAAAGGCAGTCATGCCAGATTGT >In-frame_ENST00000340541_ENST00000369443_TCGA-CD-8525-01A_VAPA_chr18_9914332_+_GDAP2_chr1_118413238_length(amino acids)=105AA_start in transcript=4_stop in transcript=321 MWDPELLTQRVAHRTGDTAAGVRAREPRAWPRPRARPSRRRRRPPPPVSKPPPRARPRSALSLRWRPPQGPWRSTSRSWSSIRPQTSNSK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for VAPA-GDAP2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for VAPA-GDAP2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for VAPA-GDAP2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | VAPA | C0005586 | Bipolar Disorder | 1 | PSYGENET |